TSE:6099Healthcare
Elan (TSE:6099) Earnings Growth And 5% Margin Reinforce Defensive Healthcare Narrative
Elan (TSE:6099) heads into Q1 2026 on the back of a steady run of results, with Q4 2025 revenue of ¥14.7b and basic EPS of ¥12.31, capped by trailing twelve month EPS of ¥45.75 alongside earnings growth of 17.5% over the last year. Over recent quarters the company has seen revenue move from ¥12.7b in Q4 2024 to ¥14.7b in Q4 2025, while quarterly EPS shifted from ¥8.64 to ¥12.31, setting up this earnings season around how firmly that roughly 5% net margin can be held or improved.
See our full...